MarketInOut Stock Screener Log In | Sign Up

DaVita Inc

NYSE • Healthcare • Medical Care Facilities • Quote as of 10/30/2026
DaVita Inc stock price and volume chart

Company Profile

IndustryMedical Care Facilities
SectorHealthcare
ExchangeNYSE
Market Capitalization11,794 mln
Float61.59 mln
Earnings Date02/11/2027

EPS

13.21
Robust

P / E

14.19
Fair value

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.7
Likely reliable

1-Year Forecast

218.71
Attractive

Relative Strength

47 / 100
In line with market

Business Description

DaVita Inc. is a Denver-based healthcare company founded in 1994 that focuses on treating patients with chronic kidney disease and kidney failure. The company runs hundreds of dialysis centers across the United States, offering treatment both in clinical settings and at patients' homes, along with supporting laboratory testing. Beyond direct patient care, DaVita also helps manage kidney disease programs for healthcare systems and provides tools to support organ transplant coordination.

Key Fundamentals

EPS13.21
P/E14.19
ROE96.79
RPS213
ROIC10.44
ROA5.05
Interest Cover3.72
EBITDA, mln2,793
EV / EBITDA9.59
EV / EBIT12.78
Revenue, mln14,168
EV / Revenue1.89

Quote Details

Last 187.50
Change -5.81 (-3.01%)
Open 175.00
Volume 1,760,621
Turnover 330,116,448
Average Volume 755,901

Financial Ratios

Pre-Tax Profit Margin11
Current Ratio1.41
Price / Cash Flow6.40
Price / Free Cash Flow9.84
Debt / Equity11.90
Price / Sales0.90
PEG Ratio1.04

Financial Strength

Altman Z-Score1.72
Piotroski F-Score 8 / 9
Beneish M-Score-2.7
Price to Intrinsic Value0.67
Price to Lynch Fair Value0.91
1-Year Target Price218.71
Shiller PE Ratio23.50
Short Ratio7.53
Short % of Float15.31

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.1% 79 / 100   
1 Month 6.32% 79 / 100   
2 Months -20.66% 10 / 100   
6 Months 23.64% 92 / 100   
1 Year 48.15% 93 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog